Biochemical and Molecular Mechanisms after Severe Traumatic Brain Injury in Children

  • P. M. Kochanek
  • R. P. Berger
  • L. W. Jenkins


Secondary damage after severe traumatic brain injury (TBI) in infants and children represents the key target for the development and application of novel therapies. Our group at the Safar Center for Resuscitation Research and the Children’s Hospital of Pittsburgh has put considerable effort into defining the mechanisms involved in the evolution of damage after severe TBI in pediatric patients and has also worked to develop and use experimental models of TBI to evaluate both novel diagnostic tools and putative therapies. In this chapter, we outline some of our most recent findings on a number of exciting fronts. First, we will update our work at the bedside that takes advantage of the cerebrospinal fluid (CSF) bank that we have accumulated from infants and children with severe TBI. The CSF bank, funded by the Centers for Disease Control and Prevention in the USA, is a unique resource that includes over 1000 CSF samples from nearly 100 pediatric victims of severe TBI. The CSF bank has become instrumental in studying biochemical and molecular mechanisms in our critically ill patients. For a review of the initial investigations of secondary injury mechanisms in pediatric TBI by our group, we suggest two recent reviews [1, 2]. The investigations by our group discussed in this chapter represent the more recent studies (Fig. 1).


Vascular Endothelial Growth Factor Traumatic Brain Injury Child Abuse Vascular Endothelial Growth Factor Level Severe Traumatic Brain Injury 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kochanek PM, Clark RSB, Ruppel RA, et al (2000) Biochemical, cellular and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: Lessons learned from the bedside. Pediatr Crit Care Med 1: 4–19PubMedCrossRefGoogle Scholar
  2. 2.
    Kochanek PM, Clark RSB, Ruppel RA, Adelson PD, Dixon CE, Jenkins L (2001) Pediatric traumatic brain injury: From bench to bedside and back In: Marwah J, Dixon E, Banik N (eds) Traumatic CNS Injury. Prominent Press, Scottsdale, pp 251–272Google Scholar
  3. 3.
    Jenkins LW, Peters GW, Dixon CE, et al (2001) Proteomic changes using large format 2D gel electrophoresis and pH 3–10 IPG strips 24 hours after CCI in 17 postnatal day (PND) rats. J Neurotrauma 18: 1151 (Abst)Google Scholar
  4. 4.
    Karkela J, Bock E, Kaukinen S (1993) CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man. J Neur Sci 116: 100–109CrossRefGoogle Scholar
  5. 5.
    Skogseid I, Nordby H, Urdal P, Paus E, Lilleaas F (1992) Increased serum creatine kinase BB and neuron specific enolase following head injury indicated brain damage. Acta Neurochir 115: 106–111PubMedCrossRefGoogle Scholar
  6. 6.
    Vazquez M, Rodriguez-Sanchez F, Osuna E, et al (1995) Creatine kinase BB and neuron specific enolase in cerebrospinal fluid in the diagnosis of brain insult. Am J Forensic Med Pathol 16: 210–214PubMedCrossRefGoogle Scholar
  7. 7.
    Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T (1995) Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head trauma. Surg Neurol 43: 267–271PubMedCrossRefGoogle Scholar
  8. 8.
    Hardemark H, Ericsson N, Kotwica Z, et al (1989) S-100 protein and neuron specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg 71: 727–731PubMedCrossRefGoogle Scholar
  9. 9.
    Clark RSB, Kochanek PM, Adelson PD, et al (2000) Increases in Bd-2 protein in cerebrospinal fluid and evidence for programmed-cell death in infants and children following severe traumatic brain injury. J Pediatrics 137: 197–204CrossRefGoogle Scholar
  10. 10.
    Berger RP, Janesko KL, Wisniewski SR, et al (2002) Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics (in press)Google Scholar
  11. 11.
    Bittigau P, Sifringer M, Pohl D, et al (1999) Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol 45: 724–735PubMedCrossRefGoogle Scholar
  12. 12.
    Kontos HA, Wei EP (1986) Superoxide production in experimental brain injury. J Neurosurg 64: 803–807PubMedCrossRefGoogle Scholar
  13. 13.
    Shohami E, Beit-Yannai E, Horowitz M, Kohen R (1997) Oxidative stress in closed head injury: Brain antioxidant capacity as an indicator of functional outcome. J Cereb Blood Flow Metab 17: 1007–1019PubMedCrossRefGoogle Scholar
  14. 14.
    Tyurin VA, Tyurina YY, Borisenko GG, et al (2000) Oxidative stress following traumatic brain injury in rats: Quantitation of biomarkers and detection of free radical intermediates. J Neurochem 75: 2178–2189PubMedCrossRefGoogle Scholar
  15. 15.
    Baylr H, Kagan VE, Tyrina YY, et al (2001) Assessment of antioxidant reserve and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr Res Suppl 49: 43A (Abst)Google Scholar
  16. 16.
    Baylr H, Marion DW, Kagan VE, et al (2002) Marked gender effect of lipid peroxidation after traumatic brain injury in adult patients. Crit Care Med (Abst, in press)Google Scholar
  17. 17.
    Muizelaar JP, Marmarou A, Young HF, et al (1993) Improving the outcome of severe head injury with oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: A phase II trial. J Neurosurg 78: 375–382PubMedCrossRefGoogle Scholar
  18. 18.
    Marshall LF, Maas AIR, Marshall SB, et al (1998) A multicenter trial on the efficacy of using tirilizad mesylate in cases of head injury. J Neurosurg 89: 519–525PubMedCrossRefGoogle Scholar
  19. 19.
    Hall ED, Andrus PK, Smith SL, et al (1997) Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models. J Pharmacol Exp Ther 281: 895–904PubMedGoogle Scholar
  20. 20.
    Robertson CL, Bell MJ, Kochanek PM, et al (2002) Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: Association with severity of injury and excitotoxicity. Crit Care Med (in press)Google Scholar
  21. 21.
    Clark RSB, Carcillo JA, Kochanek PM, et al (1997) Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery 41: 1284–1293PubMedCrossRefGoogle Scholar
  22. 22.
    Sharples PM, Stuart AG, Matthews DS, Aynsley-Green A, Eyre JA (1995) Cerebral blood flow and metabolism in children with severe head injury. Part 1: Relation to age, Glasgow coma score, outcome, intracranial pressure, and time after injury. J Neurol Neurosurg Psychiatry 58: 145–152PubMedCrossRefGoogle Scholar
  23. 23.
    Adelson PD, Clyde B, Kochanek PM, Wisniewski SR, Marion DW, Yonas H (1997) Cerebro-vascular response in infants and young children following severe traumatic brain injury: A preliminary report. Pediatr Neurosurg 26: 200–207PubMedCrossRefGoogle Scholar
  24. 24.
    Dragunow M, Sirimanne E, Lawlor PA, Williams C, Gluckman P (1992) Accumulation of calcitonin-gene related peptide-like immunoreactivity after hypoxic-ischaemic brain injury in the infant rat. Mol Brain Res 14: 267–272PubMedCrossRefGoogle Scholar
  25. 25.
    Wimalawansa SJ (1997) Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: A peptide superfamily. Crit Rev Neurobiol 11: 167–239PubMedCrossRefGoogle Scholar
  26. 26.
    Kitamura K, Kangawa K, Kawamoto M, et al (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192: 553–560PubMedCrossRefGoogle Scholar
  27. 27.
    Han YH, Carcillo JA, Ruppel RA, et al (2002) Cerebrospinal fluid procalcitonin is increased after traumatic brain injury in children. Pediatr Crit Care Med (in press)Google Scholar
  28. 28.
    Robertson CL, Minamino N, Ruppel R, et al (2001) Increased adrenomedullin in cerebrospinal fluid after traumatic brain injury in infants and children. J Neurotrauma 18: 861–868PubMedCrossRefGoogle Scholar
  29. 29.
    Wang X, Yue T, Barone FC, et al (1995) Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc Natl Acad Sci USA 92: 11480–11484PubMedCrossRefGoogle Scholar
  30. 30.
    Dogan A, Suzuki Y, Koketsu N, et al (1997) Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 17: 19–25PubMedCrossRefGoogle Scholar
  31. 31.
    Kochanek PM, Hendrich KS, Melick JA, et al (2001) Adenosine-receptor agonists attenuate posttraumatic cerebral Hypoperfusion in rats: Perfusion MRI assessment. J Neurotrauma 18: 1184 (Abst)Google Scholar
  32. 32.
    Armstead WM (1999) Role of endothelin-1 in age-dependent cerebrovascular hypotensive responses after brain injury. Am J Physiol 277: H1884 - H1894PubMedGoogle Scholar
  33. 33.
    Kelly DF, Kozlowski DA, Haddad E, Echiverri A, Hovda DA, Lee SM (2000) Ethanol reduces metabolic uncoupling following experimental head injury. J Neurotrauma 17: 261–272PubMedCrossRefGoogle Scholar
  34. 34.
    DeKosky ST, Ikonomovic MD, Wisniewski SR, et al (1999) Post-trauma levels of cytokines and growth factors in adult and pediatric CSF. J Neurotrauma 16: 994Google Scholar
  35. 35.
    Shore PM, Jackson EK, Janesko KL, et al (2001) Vascular endothelial growth factor is increased in CSF after traumatic brain injury in children. J Neurotrauma 18: 1186Google Scholar
  36. 36.
    Fink EL, Satchell MA, Kochanek PM, et al (2002) Cerebrospinal fluid analysis of hepatocyte growth factor concentration in infants and children after traumatic brain injury. Crit Care Med (Abst, in press)Google Scholar
  37. 37.
    Ferrara N (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527–543PubMedCrossRefGoogle Scholar
  38. 38.
    Nag S, Takahashi JL, Kilty DW (1997) Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J Neuropathol Exp Neurol 56: 912–921PubMedCrossRefGoogle Scholar
  39. 39.
    Jin KL, Mao XO, Greenberg DA (2000) Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 97: 10242–10247PubMedCrossRefGoogle Scholar
  40. 40.
    Fey SJ, Larsen PM (2001) 2D or not 2D. Curr Opin Chem Biol 5: 26–33Google Scholar
  41. 41.
    O’Farrell PH (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007–4021PubMedGoogle Scholar
  42. 42.
    Adelson PD, Skinner JC, Davis DS, et al (2000) A model of focal TBI in the neonatal rat. J Neurotrauma 17: 969CrossRefGoogle Scholar
  43. 43.
    Jenkins L, Dixon CE, Peters G, Gao W, Zhang X, Kochanek PM (2001) Cell signaling: serine/threonine protein kinases and traumatic brain injury. In: Clark RSB, Kochanek PM (eds) Brain Injury. Kluwer Academic Publishers, BostonGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • P. M. Kochanek
  • R. P. Berger
  • L. W. Jenkins

There are no affiliations available

Personalised recommendations